Company page

Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. is a public company traded under the ticker PLRX on the American market. The company has a market capitalization of approximately $67.5 million. Pliant focuses on developing innovative therapies for fibrotic diseases, aiming to address significant unmet medical needs.